Nordea Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.35M | Buy |
10,618
+344
| +3% | +$76K | ﹤0.01% | 702 |
|
|
2025
Q1 | $2.28M | Buy |
10,274
+3,932
| +62% | +$873K | ﹤0.01% | 677 |
|
|
2024
Q4 | $2.09M | Buy |
6,342
+203
| +3% | +$66.8K | ﹤0.01% | 684 |
|
|
2024
Q3 | $1.87M | Sell |
6,139
-31,044
| -83% | -$9.44M | ﹤0.01% | 704 |
|
|
2024
Q2 | $12.4M | Sell |
37,183
-189
| -0.5% | -$63K | 0.01% | 374 |
|
|
2024
Q1 | $14.8M | Buy |
37,372
+265
| +0.7% | +$105K | 0.02% | 369 |
|
|
2023
Q4 | $13.1M | Sell |
37,107
-347
| -0.9% | -$123K | 0.02% | 369 |
|
|
2023
Q3 | $14.2M | Sell |
37,454
-617
| -2% | -$233K | 0.02% | 336 |
|
|
2023
Q2 | $14.6M | Sell |
38,071
-1,617
| -4% | -$620K | 0.02% | 345 |
|
|
2023
Q1 | $13.8M | Buy |
39,688
+513
| +1% | +$178K | 0.02% | 330 |
|
|
2022
Q4 | $9.17M | Sell |
39,175
-9,797
| -20% | -$2.29M | 0.01% | 396 |
|
|
2022
Q3 | $12.3M | Sell |
48,972
-36,047
| -42% | -$9.05M | 0.02% | 336 |
|
|
2022
Q2 | $25.3M | Buy |
85,019
+52,977
| +165% | +$15.7M | 0.04% | 279 |
|
|
2022
Q1 | $13.5M | Sell |
32,042
-1,896
| -6% | -$796K | 0.02% | 357 |
|
|
2021
Q4 | $16M | Sell |
33,938
-19
| -0.1% | -$8.93K | 0.02% | 342 |
|
|
2021
Q3 | $14.9M | Sell |
33,957
-982
| -3% | -$430K | 0.02% | 346 |
|
|
2021
Q2 | $12.5M | Sell |
34,939
-2,655
| -7% | -$953K | 0.02% | 358 |
|
|
2021
Q1 | $10.5M | Buy |
37,594
+1,234
| +3% | +$343K | 0.02% | 371 |
|
|
2020
Q4 | $10.3M | Buy |
36,360
+4,005
| +12% | +$1.13M | 0.02% | 358 |
|
|
2020
Q3 | $8.84M | Buy |
32,355
+23,097
| +249% | +$6.31M | 0.02% | 347 |
|
|
2020
Q2 | $2.04M | Buy |
9,258
+5,537
| +149% | +$1.22M | ﹤0.01% | 717 |
|
|
2020
Q1 | $582K | Hold |
3,721
| – | – | ﹤0.01% | 773 |
|
|
2019
Q4 | $564K | Buy |
+3,721
| New | +$564K | ﹤0.01% | 830 |
|